KIRAN DEVARAJ: Open Payments
NPI 1003878984 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 61 payments from 17 companies in 2025. Trend: 2023 $1,314 · 2024 $2,728 · 2025 $1,667
Food & beverage: $1,454Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $345 |
| ABBVIE INC. | 13 | $313 |
| Janssen Pharmaceuticals, Inc | 8 | $259 |
| AstraZeneca Pharmaceuticals LP | 1 | $105 |
| Lundbeck LLC | 4 | $89 |
| Sage Therapeutics, LLC | 3 | $80 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Alkermes, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
Products named: VRAYLAR, SPRAVATO, REXULTI, AIRSUPRA, UZEDY, ZURZUVAE, Jornay PM, TRINTELLIX.
Industry payments across WV — which companies pay providers there.
